Pete Wilson is a partner and head of the U.K. private equity team at 3i Group, based in London. Wilson told Buyouts in a recent interview how the global private equity firm uses an international approach in everything it does. Can you elaborate on 3i’s international focus? Our international angle is probably about three things: […]
Canadian healthcare technology venture firm iGan Partners has named Mark Bhattacharya as its new chief financial officer and chief operating officer. Previously, he worked at Morneau Shepell Asset and Risk Management Ltd where he was head of operations and chief compliance officer. Last year, iGan closed its debut fund at $100 million.
Maryland-based WD Lab Grown Diamonds, a producer of laboratory grown diamonds for the jewelry, scientific and industrial markets, has named Sue Rechner as CEO. She is the former global president of Merrell, the largest division of Wolverine Worldwide. WD is backed by Huron Capital.
Livingstone, an international M&A mid-market M&A and debt advisory firm, has named Mark Birkett and Michael Jenny as partners. Prior to joining Livingstone, Birkett worked at William Blair while Jenny was at Houlihan Lokey.
Argand Partners has promoted Ryan Beres to senior associate. Prior to joining the middle-market buyout firm, Beres was an investment banking analyst at Goldman Sachs.
Houlihan Lokey has named Sean Fitzgerald as a managing director in the capital markets group. Previously, he worked at Macquarie Capital, where he was a managing director and co-head of U.S. private capital markets.
PlainID, a provider of an advanced authorization platform, has named Richard Bauer as global vice president of sales. PlainID's backers include Viola Ventures.
Austin-based Santé Ventures, a healthcare and life sciences investment firm, has appointed Eric Epstein as senior associate. Previously, he worked at McKinsey & Company where he was an engagement manager.
TZP Group has expanded its team with several new hires and promotions. Joining the private equity firm are Shamit Mehta as partner for growth equity; JoAnne Kruse as portfolio operations partner for talent; Michael Khutorsky as principal; Jarrad Berman as portfolio operations vice president for digital; and Marco Luy as associate. Among the TZP staffers who were recently promoted were Sheera Michael who's now a partner; Harrison Davis, who's now a principal and Matt Doherty, Manvir Heir and Ryan McCarthy, who are all senior associates.
UK-based Artios Pharma Limited, a DNA damage response company developing treatments for cancer, has named Tania Dimitrova as chief business officer. Previously, she worked at Pfizer Inc where she was a director in worldwide business development. Artios is backed by Arix Bioscience plc, SV Health Investors, M Ventures, IP Group plc, AbbVie Ventures, Andera Partners, LSP, Pfizer Ventures and Novartis Venture Fund.